BusinessActinium Pharmaceuticals to Present Actimab-A Data at the 10th International Symposium on Targeted Alpha TherapyBy Nasdaq OMXMay 23, 2017, 11:32 AM UTC
BusinessActinium Pharmaceuticals to Present Actimab-A Data at the 10th International Symposium on Targeted Alpha TherapyBy Nasdaq OMXMay 23, 2017, 11:32 AM UTC
BusinessActinium Pharmaceuticals Announces Appointment of Hematology Expert Dr. Richard Stone of the Dana-Farber Cancer Institute to its Scientific Advisory BoardBy Nasdaq OMXMay 17, 2017, 11:01 AM UTC
BusinessActinium Pharmaceuticals Announces Appointment of Hematology Expert Dr. Richard Stone of the Dana-Farber Cancer Institute to its Scientific Advisory BoardBy Nasdaq OMXMay 17, 2017, 11:01 AM UTC
BusinessActinium Pharmaceuticals Announces Sponsorship of the Acute Leukemia Forum 2017By Nasdaq OMXApr 18, 2017, 11:00 AM UTC
BusinessCellular Biomedicine Group (CBMG) Approved to Commence Phase I Trial (CALL-1) for C-CAR011 in Adult Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia (ALL) in ChinaBy Nasdaq OMXJan 9, 2017, 11:11 AM UTC
